Supporting information for design, synthesis, anti-tumor activity and mechanism of novel PROTACs as degraders of PD-Ll and inhibitors of PD-1/PD-L1 interaction
Published: 7 March 2024| Version 1 | DOI: 10.17632/xgww25d52t.1
Contributors:
feng zhang, Description
Supporting information for design, synthesis, anti-tumor activity and mechanism of novel PROTACs as degraders of PD-Ll and inhibitors of PD-1/PD-L1 interaction
Files
Institutions
Zhejiang University of Technology
Categories
Pharmacy, Pharmaceutical Chemistry, Drug Synthesis
Funding
National Natural Science Foundation of China-China Academy of General Technology Joint Fund for Basic Research
21877101, 22177105
Zhejiang Provincial Key Discipline of Chemical Biology.